Works matching IS 15391604 AND DT 2022 AND VI 21 AND IP 1

Results: 18

A two‐stage drop‐the‐losers design for time‐to‐event outcome using a historical control arm.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 268, doi. 10.1002/pst.2168

By:

Abbas, Rachid;
Wason, James;
Michiels, Stefan;
Le Teuff, Gwénaël

Publication type:

Article

Methodological challenges in the analysis of recurrent events for randomised controlled trials with application to cardiovascular events in LEADER.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 241, doi. 10.1002/pst.2167

By:

Furberg, Julie Kjærulff;
Rasmussen, Søren;
Andersen, Per Kragh;
Ravn, Henrik

Publication type:

Article

Flexible diagnostic measures and new cut‐point selection methods under multiple ordered classes.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 220, doi. 10.1002/pst.2166

By:

Feng, Yingdong;
Tian, Lili

Publication type:

Article

Robust estimates of regional treatment effects in multiregional randomized clinical trials with semiparametric logistic model.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 133, doi. 10.1002/pst.2157

By:

Yuan, Ao;
Yang, Chaojie;
Yu, Shilin;
Tan, Ming T.

Publication type:

Article

Multiple imputation analysis of Miettinen‐Nurminen interval for difference in proportions.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 196, doi. 10.1002/pst.2162

By:

Lu, Kaifeng;
Guo, Hua

Publication type:

Article

Confidence intervals for exposure‐adjusted rate differences in randomized trials.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 103, doi. 10.1002/pst.2155

By:

Scosyrev, Emil;
Pethe, Abhijit

Publication type:

Article

Counterfactual mediation analysis in the multistate model framework for surrogate and clinical time‐to‐event outcomes in randomized controlled trials.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 163, doi. 10.1002/pst.2159

By:

Weir, Isabelle R.;
Rider, Jennifer R.;
Trinquart, Ludovic

Publication type:

Article

Estimands for overall survival in clinical trials with treatment switching in oncology.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 150, doi. 10.1002/pst.2158

By:

Manitz, Juliane;
Kan‐Dobrosky, Natalia;
Buchner, Hannes;
Casadebaig, Marie‐Laure;
Degtyarev, Evgeny;
Dey, Jyotirmoy;
Haddad, Vincent;
Jie, Fei;
Martin, Emily;
Mo, Mindy;
Rufibach, Kaspar;
Shentu, Yue;
Stalbovskaya, Viktoriya;
Tang, Rui;
Yung, Godwin;
Zhou, Jiangxiu

Publication type:

Article

Using an interim analysis based exclusively on an early outcome in a randomized clinical trial with a long‐term clinical endpoint.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 209, doi. 10.1002/pst.2165

By:

Garcia Barrado, Leandro;
Burzykowski, Tomasz;
Legrand, Catherine;
Buyse, Marc

Publication type:

Article

Operational characteristics of generalized pairwise comparisons for hierarchically ordered endpoints.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 122, doi. 10.1002/pst.2156

By:

Deltuvaite‐Thomas, Vaiva;
Burzykowski, Tomasz

Publication type:

Article

Incorporating covariates information in adaptive clinical trials for precision medicine.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 176, doi. 10.1002/pst.2160

By:

Zhao, Wanying;
Ma, Wei;
Wang, Fan;
Hu, Feifang

Publication type:

Article

Sample size calculation for recurrent event data with additive rates models.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 89, doi. 10.1002/pst.2154

By:

Zhu, Liang;
Li, Yimei;
Tang, Yongqiang;
Shen, Liji;
Onar‐Thomas, Arzu;
Sun, Jianguo

Publication type:

Article

Flexible parametric copula modeling approaches for clustered survival data.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 69, doi. 10.1002/pst.2153

By:

Kwon, Sookhee;
Ha, Il Do;
Shih, Jia‐Han;
Emura, Takeshi

Publication type:

Article

Separation and the information theory surrogate evaluation approach: A penalised likelihood solution.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 55, doi. 10.1002/pst.2152

By:

Ensor, Hannah;
Weir, Christopher J.

Publication type:

Article

Adjusting for covariates in analysis based on restricted mean survival times.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 38, doi. 10.1002/pst.2151

By:

Zhong, Yi;
Zhao, Ou;
Zhang, Bo;
Yao, Bin

Publication type:

Article

Identifying treatment effect heterogeneity in dose‐finding trials using Bayesian hierarchical models.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 17, doi. 10.1002/pst.2150

By:

Thomas, Marius;
Bornkamp, Björn;
Ickstadt, Katja

Publication type:

Article

A unified approach for evaluating the prediction of treatment effect across different types of endpoints.

Published in:

Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 4, doi. 10.1002/pst.2149

By:

Qu, Yongming;
Park, So Young;
Wu, Qiwei;
Shen, Wei

Publication type:

Article

Issue Information.

Published in:: Pharmaceutical Statistics, 2022, v. 21, n. 1, p. 1, doi. 10.1002/pst.2133
Publication type:: Article